Sun Pharmaceuticals | SUNP - Gross Profit On Sales


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Sun Pharmaceuticals

Sun Pharmaceuticals reported INR86.8B in Gross Profit on Sales for its fiscal quarter ending in March of 2023.


Gross Profit On Sales Change
Aspen Pharmacare APN:SJ ZAR 8.97B 55M
Bharat Petroleum BPCL:IN INR 178.86B 68.93B
Cipla CIPLA:IN INR 36.76B 1.3B
Dr.Reddys Laboratories DRRD:IN INR 36B 11.89B
Sh Fosun Pharma 600196:CH CNY 5.51B 507.77M
Sun Pharmaceuticals SUNP:IN INR 86.8B 2.43B
UPL UPLL:IN INR 67.48B 4.77B